An Alternatively Spliced p62 Isoform Confers Resistance to Chemotherapy in Breast Cancer.
Qianying GuoHao WangJiahao DuanWenwu LuoRongrong ZhaoYuting ShenBijun WangSiqi TaoYi SunQian YeXiaomin BiHui YuanQiang WuPeter E LobieTao ZhuSheng TanXing HuangZheng-Sheng WuPublished in: Cancer research (2022)
Resistance to NAC in breast cancer is driven by a novel p62 mRNA isoform that escapes miRNA-mediated repression and leads to increased p62 protein expression.